DealPulse Signal Wk 41: McKesson Bought Into Home Infusion and Shionogi Bought the Next Label
Three takeovers lifted paid at signing to 80%. Four licences paid 17%, and a profit split carried the rest of the risk.
NeuroPulse
DealPulse Signal
The Beats
Analysis
The Briefs
The FTC Warned 24 Large Healthcare Companies That Following CMS Price Rules Is No Shield Against a Deception Case
One Price in Japan, Response-Linked Payments in Australia and No Public Price in China: In Asia-Pacific the Payer Sets the CAR-T Price
CMS Set December 2027 for Insurers’ Prescription Drug Price Files, a Requirement on Hold Since 2021
Only one Member State was assessing each valve when Brussels chose them, so the joint report will frame the evidence.
Korea’s First Homegrown GLP-1 Cut Weight 9.75% at 40 Weeks, So Hanmi Will Fight Wegovy and Mounjaro on Price and Supply
